ARTICLE | Clinical News
Peg-Intron peginterferon alfa-2b regulatory update
August 8, 2005 7:00 AM UTC
CHMP issued a positive opinion recommending approval for a shorter 24-week course of Peg-Intron pegylated recombinant interferon alfa-2b in combination with SGP's Rebetol ribavirin in patients with H...